# HBIO (Harvard Bioscience, Inc.) - SEC EDGAR Financial Statements

> Harvard Bioscience, Inc. reported $89.41M in revenue and a net loss of $11.80M for the trailing twelve months ended September 30, 2026 (up 7.8% year over year), with a 57.4% gross margin and a -1.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/HBIO
- Markdown: https://convexityos.com/fundamentals/HBIO.md
- SEC CIK: 0001123494
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001123494&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $89.41M | +7.8% YoY |
| Operating Income | TTM | -$1.59M | -1.8% margin |
| Net Income | TTM | -$11.80M | -13.2% net margin |
| Diluted EPS | TTM | -$2.59 | Split-adjusted |
| Free Cash Flow | TTM | -$3.17M | -3.5% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $4.86M | Total debt: $44.29M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $86.55M | $94.14M | $112.2M | $113.3M | $118.9M | $102.1M | $116.2M | $120.8M | $77.41M | $104.5M |
| Cost of Revenue | $36.64M | $39.37M | $46.18M | $52.52M | $51.25M | $44.06M | $51.85M | $57.59M | $38.24M | $56.11M |
| **Gross Profit** | $49.91M | $54.77M | $66.07M | $60.82M | $67.65M | $58.04M | $64.32M | $63.18M | $39.17M | $48.41M |
| Research & Development | $8.82M | $10.41M | $11.76M | $12.33M | $10.80M | $8.69M | $10.71M | $10.99M | $5.64M | $5.39M |
| Selling, General & Admin | $36.96M | $43.70M | $46.82M | $49.53M | $48.95M | $43.42M | $46.02M | $45.83M | $32.61M | $41.44M |
| Total Operating Expenses | $98.49M | $60.98M | $64.18M | $67.75M | $65.59M | $57.82M | $63.95M | $62.20M | $39.80M | $51.41M |
| **Operating Income** | -$48.58M | -$6.21M | $1.89M | -$6.93M | $2.07M | $221K | $377K | $984K | -$635K | -$3.00M |
| **EBITDA** | -$42.81M | $771K | $8.89M | $642K | $9.69M | $7.85M | $8.11M | $8.79M | $2.23M | $1.26M |
| Interest Expense | $1.30M | $800K | -- | -- | -- | -- | -- | $5.37M | $713K | $639K |
| Income Before Tax | -$57.39M | -$11.66M | -$2.56M | -$9.18M | -$140K | -$7.29M | -$5.50M | -$7.97M | -$2.62M | -$3.08M |
| Income Tax Expense | -$686K | $740K | $859K | $337K | $148K | $518K | -$815K | -$3.68M | -$605K | $1.23M |
| **Net Income** | -$56.70M | -$12.40M | -$3.42M | -$9.52M | -$288K | -$7.81M | -$4.69M | -$2.92M | -$865K | -$4.31M |
| Basic EPS | -$1.28 | -$0.28 | -$0.08 | -$0.23 | -$0.01 | -$0.20 | -$0.12 | -$0.08 | -$0.02 | -$0.13 |
| **Diluted EPS** | -$1.28 | -$0.28 | -$0.08 | -$0.23 | -$0.01 | -$0.20 | -$0.12 | -$0.08 | -$0.02 | -$0.13 |
| Basic Shares Outstanding | 44.4M | 43.5M | 42.4M | 41.4M | 40.3M | 38.6M | 37.8M | 36.5M | 34.8M | 34.2M |
| Diluted Shares Outstanding | 44.4M | 43.5M | 42.4M | 41.4M | 40.3M | 38.6M | 37.8M | 36.5M | 34.8M | 34.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $22.20M | $22.73M | $20.75M | $23.73M | $20.59M | $20.45M | $21.77M | $24.56M |
| Cost of Revenue | $9.89M | $10.10M | $8.51M | $9.56M | $8.57M | $8.92M | $9.59M | $10.54M |
| **Gross Profit** | $12.31M | $12.63M | $12.24M | $14.17M | $12.02M | $11.53M | $12.18M | $14.01M |
| Research & Development | $2.26M | $2.45M | $2.33M | $2.18M | $2.13M | $2.19M | $2.32M | $2.33M |
| Selling, General & Admin | $10.18M | $10.02M | $10.04M | $9.21M | $8.79M | $8.80M | $10.16M | $10.20M |
| Total Operating Expenses | $13.46M | $13.61M | $13.42M | $12.46M | $11.82M | $12.35M | $61.85M | $14.00M |
| **Operating Income** | -$1.15M | -$978K | -$1.17M | $1.71M | $197K | -$819K | -$49.67M | $11K |
| **EBITDA** | -$285K | $309K | $89K | $3.02M | $1.48M | $754K | -$48.06M | $1.73M |
| Interest Expense | $1.30M | $1.30M | -- | -- | $1.00M | $800K | -- | -- |
| Income Before Tax | -$2.69M | -$2.90M | -$3.31M | -$3.20M | -$1.13M | -$2.25M | -$50.79M | $590K |
| Income Tax Expense | -$72K | $14K | $117K | -$357K | $97K | $28K | -$454K | $572K |
| **Net Income** | -$2.62M | -$2.91M | -$3.42M | -$2.85M | -$1.23M | -$2.28M | -$50.34M | $18K |
| Basic EPS | -$0.58 | -$0.06 | -$0.08 | -- | -$0.28 | -$0.05 | -$1.14 | -- |
| **Diluted EPS** | -$0.58 | -$0.06 | -$0.08 | -- | -$0.28 | -$0.05 | -$1.14 | -- |
| Basic Shares Outstanding | 4.6M | 45.3M | 44.7M | -- | 4.5M | 44.3M | 44.1M | -- |
| Diluted Shares Outstanding | 4.6M | 45.3M | 44.7M | -- | 4.5M | 44.3M | 44.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.61M | $4.11M | $4.28M | $4.51M | $7.82M | $8.32M | $8.34M | $8.17M | $5.73M | $5.60M |
| **Cash & Short-Term Investments** | $8.61M | $4.11M | $4.28M | $4.51M | $7.82M | $8.32M | $8.34M | $8.17M | $5.73M | $5.60M |
| Accounts Receivable, Net | $16.04M | $14.87M | $16.10M | $16.70M | $21.83M | $17.77M | $20.70M | $21.46M | $13.38M | $15.75M |
| Inventory | $20.80M | $23.25M | $24.72M | $26.44M | $27.59M | $22.26M | $22.06M | $25.09M | $16.85M | $19.95M |
| Other Current Assets | $2.76M | $2.90M | $3.94M | $3.47M | $4.34M | $3.35M | $2.47M | $3.11M | $3.71M | $4.17M |
| **Total Current Assets** | $48.23M | $45.12M | $49.04M | $51.12M | $61.58M | $51.70M | $53.57M | $57.83M | $47.53M | $45.47M |
| Property, Plant & Equipment, Net | $4.79M | $5.11M | $3.98M | $3.37M | $3.42M | $3.96M | $4.78M | $5.90M | $3.74M | $4.30M |
| Goodwill | $9.56M | $56.32M | $57.06M | $56.26M | $57.69M | $58.59M | $57.38M | $57.30M | $36.34M | $38.03M |
| Intangible Assets | $7.64M | $11.13M | $16.04M | $21.01M | $27.39M | $33.15M | $38.41M | $45.76M | $10.03M | $17.47M |
| Other Non-Current Assets | $2.69M | $2.83M | $6.47M | $7.78M | $5.38M | $1.09M | $2.27M | $1.81M | $324K | $128K |
| **Total Non-Current Assets** | $31.85M | $81.53M | $88.33M | $94.24M | $100.8M | $104.6M | $111.3M | $110.8M | $61.82M | $62.29M |
| **Total Assets** | $80.07M | $126.6M | $137.4M | $145.4M | $162.3M | $156.3M | $164.9M | $168.6M | $109.4M | $107.8M |
| Accounts Payable | $3.65M | $4.79M | $5.55M | $6.45M | $4.91M | $5.97M | $5.34M | $7.36M | $4.41M | $6.20M |
| Short-Term Debt | $0 | $36.96M | $6.14M | $4.09M | $3.52M | $2.00M | $3.20M | $2.40M | -- | -- |
| Deferred Revenue (Current) | $3.45M | $3.81M | $4.51M | $3.37M | $4.27M | $3.77M | $3.95M | $3.82M | $505K | $500K |
| Other Current Liabilities | $14.86M | $9.41M | $10.62M | $7.49M | $10.76M | $7.48M | $6.70M | $7.35M | $293K | $760K |
| **Total Current Liabilities** | $21.96M | $54.96M | $26.54M | $23.25M | $25.32M | $21.05M | $25.31M | $25.49M | $14.04M | $14.60M |
| Long-Term Debt | $35.87M | $0 | $30.70M | $43.01M | $45.09M | $46.29M | $46.92M | $54.81M | $8.98M | $11.37M |
| Other Non-Current Liabilities | $1.31M | $1.25M | $1.48M | $1.01M | $486K | $2.85M | $749K | $3.29M | -- | -- |
| **Total Non-Current Liabilities** | $44.38M | $8.35M | $37.75M | $49.89M | $53.63M | $58.52M | $57.86M | $60.40M | $14.41M | $20.97M |
| **Total Liabilities** | $66.34M | $63.30M | $64.29M | $73.14M | $78.94M | $79.57M | $83.18M | $85.89M | $28.45M | $35.57M |
| **Total Debt (incl. Leases)** | $44.28M | $44.49M | $43.05M | $54.52M | $57.24M | $57.88M | $60.77M | $57.21M | $8.98M | $11.37M |
| Common Stock | $45K | $441K | $434K | $454K | $452K | $444K | $438K | $436K | $419K | $418K |
| Retained Earnings | -$214.7M | -$158.0M | -$145.6M | -$142.2M | -$132.7M | -$132.4M | -$124.6M | -$119.9M | -$117.0M | -$116.0M |
| Accumulated Other Comp. Income | -$11.67M | -$15.67M | -$14.19M | -$15.05M | -$10.03M | -$13.07M | -$12.69M | -$13.53M | -$10.68M | -$16.66M |
| **Total Stockholders' Equity** | $13.73M | $63.34M | $73.07M | $72.22M | $83.40M | $76.68M | $81.69M | $82.72M | $80.90M | $72.20M |
| Total Equity | $13.73M | $63.34M | $73.07M | $72.22M | $83.40M | $76.68M | $81.69M | $82.72M | $80.90M | $72.20M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.86M | $6.50M | $7.10M | $8.61M | $6.82M | $7.44M | $5.55M | $4.11M |
| **Cash & Short-Term Investments** | $4.86M | $6.50M | $7.10M | $8.61M | $6.82M | $7.44M | $5.55M | $4.11M |
| Accounts Receivable, Net | $14.91M | $14.50M | $14.57M | $16.04M | $12.11M | $11.94M | $13.48M | $14.87M |
| Inventory | $23.49M | $22.23M | $22.20M | $20.80M | $21.60M | $22.25M | $22.82M | $23.25M |
| Other Current Assets | $2.72M | $3.23M | $3.60M | $2.76M | $3.27M | $3.33M | $3.06M | $2.90M |
| **Total Current Assets** | $45.98M | $46.46M | $47.48M | $48.23M | $43.80M | $44.97M | $44.90M | $45.12M |
| Property, Plant & Equipment, Net | $5.40M | $5.35M | $4.87M | $4.79M | $4.99M | $4.91M | $5.01M | $5.11M |
| Goodwill | $9.30M | $9.33M | $9.37M | $9.56M | $9.53M | $10.15M | $8.96M | $56.32M |
| Intangible Assets | $6.18M | $6.22M | $6.91M | $7.64M | $8.38M | $9.14M | $10.13M | $11.13M |
| Other Non-Current Assets | $2.46M | $2.53M | $2.58M | $2.69M | $3.79M | $3.79M | $3.52M | $2.83M |
| **Total Non-Current Assets** | $29.32M | $29.82M | $30.46M | $31.85M | $34.19M | $35.12M | $34.90M | $81.53M |
| **Total Assets** | $75.30M | $76.29M | $77.94M | $80.07M | $77.99M | $80.09M | $79.80M | $126.6M |
| Accounts Payable | $7.16M | $6.22M | $5.29M | $3.65M | $5.18M | $4.72M | $4.81M | $4.79M |
| Short-Term Debt | $0 | $0 | $0 | $0 | -- | -- | -- | $36.96M |
| Deferred Revenue (Current) | $3.10M | $3.60M | $3.67M | $3.45M | $2.88M | $3.14M | $3.43M | $3.81M |
| Other Current Liabilities | $15.87M | $14.97M | $14.91M | $14.86M | $12.37M | $12.47M | $11.41M | $9.41M |
| **Total Current Liabilities** | $26.13M | $24.79M | $23.86M | $21.96M | $54.40M | $55.20M | $55.60M | $54.96M |
| Long-Term Debt | $37.15M | $36.68M | $36.21M | $35.87M | $33.97M | $34.90M | $36.40M | $0 |
| Other Non-Current Liabilities | $1.16M | $1.16M | $1.15M | $1.31M | $1.46M | $1.43M | $1.42M | $1.25M |
| **Total Non-Current Liabilities** | $44.07M | $44.08M | $44.03M | $44.38M | $9.53M | $9.16M | $9.36M | $8.35M |
| **Total Liabilities** | $70.19M | $68.87M | $67.89M | $66.34M | $63.92M | $64.36M | $64.97M | $63.30M |
| **Total Debt (incl. Leases)** | $44.29M | $44.21M | $44.12M | $44.28M | $42.78M | $43.72M | $45.05M | $44.49M |
| Common Stock | $46K | $447K | $447K | $45K | $446K | $445K | $442K | $441K |
| Retained Earnings | -$223.7M | -$221.0M | -$218.1M | -$214.7M | -$211.9M | -$210.6M | -$208.3M | -$158.0M |
| Accumulated Other Comp. Income | -$12.46M | -$12.38M | -$12.31M | -$11.67M | -$12.44M | -$11.70M | -$14.36M | -$15.67M |
| **Total Stockholders' Equity** | $5.11M | $7.42M | $10.05M | $13.73M | $14.07M | $15.73M | $14.84M | $63.34M |
| Total Equity | $5.11M | $7.42M | $10.05M | $13.73M | $14.07M | $15.73M | $14.84M | $63.34M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$56.70M | -$12.40M | -$3.42M | -$9.52M | -$288K | -$7.81M | -$4.69M | -$2.92M | -$865K | -$4.31M |
| Depreciation & Amortization | $5.77M | $6.98M | $7.00M | $7.58M | $7.62M | $7.63M | $7.73M | $7.81M | $2.87M | $4.25M |
| Stock-Based Compensation | $1.85M | $4.34M | $5.00M | $4.41M | $4.17M | $3.65M | $3.03M | $3.04M | $3.50M | $3.50M |
| Change in Receivables | -$934K | $974K | $810K | $4.78M | -$4.29M | $3.10M | $468K | -$2.79M | $196K | $566K |
| Change in Inventory | $2.95M | -$64K | $1.52M | $252K | -$5.86M | $413K | $3.26M | $2.55M | -$548K | $1.25M |
| Change in Payables | -- | -- | -- | -- | -- | $511K | -$2.05M | $1.59M | -$918K | -$2.41M |
| **Operating Cash Flow** | $6.73M | $1.44M | $14.03M | $1.15M | $1.26M | $9.33M | $8.04M | $2.88M | $1.06M | $5.38M |
| Capital Expenditure | -$1.26M | -$2.64M | -$1.79M | -$1.59M | -$1.20M | -$1.15M | -$1.22M | -$986K | -$890K | -- |
| **Free Cash Flow** | $5.47M | -$1.20M | $12.24M | -$438K | $67K | $8.18M | $6.83M | $1.90M | $167K | -- |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -- | -$68.55M | $0 | $0 |
| **Investing Cash Flow** | -$1.86M | -$1.34M | -$1.80M | -$1.59M | -$1.34M | -$1.40M | -$229K | -$53.80M | -$917K | -$62K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $4.56M | $160K | $182K |
| **Financing Cash Flow** | -$1.29M | -$131K | -$12.13M | -$2.84M | -$252K | -$7.97M | -$7.62M | $53.05M | -$1.79M | -$4.87M |
| **Net Change in Cash** | $4.51M | -$175K | -$225K | -$3.31M | -$496K | -$18K | $162K | $2.44M | $137K | -$1.15M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.62M | -$2.91M | -$3.42M | -$2.85M | -$1.23M | -$2.28M | -$50.34M | $18K |
| Depreciation & Amortization | $865K | $1.29M | $1.26M | $1.31M | $1.28M | $1.57M | $1.61M | $1.72M |
| Stock-Based Compensation | $436K | $380K | $257K | $459K | $324K | $472K | $600K | $961K |
| Change in Receivables | -$418K | $58K | $1.41M | -$3.96M | -$210K | $1.79M | $1.44M | -$2.33M |
| Change in Inventory | -$1.19M | -$184K | -$1.54M | $663K | $637K | $977K | $670K | $2.35M |
| **Operating Cash Flow** | -$248K | $325K | -$662K | -$96K | $1.08M | $2.75M | $2.99M | $1.73M |
| Capital Expenditure | -$927K | -$688K | -$426K | -$449K | -$207K | -$89K | -$513K | -$301K |
| **Free Cash Flow** | -$1.18M | -$363K | -$1.09M | -$545K | $877K | $2.67M | $2.47M | $1.42M |
| **Investing Cash Flow** | -$1.34M | -$916K | -$620K | -$599K | -$348K | -$233K | -$683K | -$466K |
| **Financing Cash Flow** | -$45K | -$38K | -$9.0K | $2.45M | -$1.28M | -$1.26M | -$1.20M | -$1.36M |
| **Net Change in Cash** | -$1.65M | -$595K | -$1.52M | $1.80M | -$625K | $1.90M | $1.44M | -$461K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 57.7% | 58.2% | 58.9% | 53.7% | 56.9% | 56.8% | 55.4% | 52.3% | 50.6% | 46.3% |
| **Operating Margin** | -56.1% | -6.6% | 1.7% | -6.1% | 1.7% | 0.2% | 0.3% | 0.8% | -0.8% | -2.9% |
| **Net Profit Margin** | -65.5% | -13.2% | -3.0% | -8.4% | -0.2% | -7.6% | -4.0% | -2.4% | -1.1% | -4.1% |
| Return on Equity (ROE) | -412.8% | -19.6% | -4.7% | -13.2% | -0.3% | -10.2% | -5.7% | -3.5% | -1.1% | -6.0% |
| Return on Assets (ROA) | -70.8% | -9.8% | -2.5% | -6.5% | -0.2% | -5.0% | -2.8% | -1.7% | -0.8% | -4.0% |
| Current Ratio | 2.20x | 0.82x | 1.85x | 2.20x | 2.43x | 2.46x | 2.12x | 2.27x | 3.39x | 3.11x |
| Quick Ratio | 1.25x | 0.40x | 0.92x | 1.06x | 1.34x | 1.40x | 1.24x | 1.28x | 2.19x | 1.75x |
| Debt to Equity | 3.22x | 0.70x | 0.59x | 0.75x | 0.69x | 0.75x | 0.74x | 0.69x | 0.11x | 0.16x |
| **Revenue Growth (YoY)** | -8.1% | -16.1% | -1.0% | -4.7% | +16.5% | -12.1% | -3.8% | +56.0% | -25.9% | -3.8% |
| Gross Profit Growth (YoY) | -8.9% | -17.1% | +8.6% | -10.1% | +16.6% | -9.8% | +1.8% | +61.3% | -19.1% | -0.6% |
| Operating Income Growth (YoY) | -- | -427.9% | -- | -435.6% | +834.8% | -41.4% | -61.7% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | +367.3% | -89.7% | +1117.7% | -8.7% | -86.5% | +16.0% | +179.0% | +172.8% | -80.4% | +663.5% |
| Free Cash Flow Growth (YoY) | -- | -109.8% | -- | -753.7% | -99.2% | +19.8% | +259.8% | +1036.5% | -- | -- |
| 5Y Revenue / Share Growth | -26.2% | -29.6% | -20.1% | +22.9% | -3.5% | -18.3% | -9.0% | -4.3% | -42.3% | -20.2% |
| 10Y Revenue / Share Growth | -39.7% | -36.0% | -23.6% | -29.1% | -23.0% | -29.2% | +6.2% | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -269.3% | -- | -130.2% | -194.0% |
| 10Y Net Income / Share Growth | -- | -489.2% | -- | -379.2% | -105.3% | -130.8% | -150.8% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 57.4% | 58.2% | 58.4% | 57.7% | 56.9% | 56.9% | 57.1% | 58.2% |
| **Operating Margin** | -1.8% | -0.3% | -0.1% | -56.1% | -57.5% | -59.0% | -58.6% | -6.6% |
| **Net Profit Margin** | -13.2% | -11.9% | -11.4% | -65.5% | -61.6% | -64.7% | -63.5% | -13.2% |
| Return on Equity (ROE) | -231.2% | -140.4% | -97.4% | -412.8% | -382.7% | -364.9% | -391.3% | -19.6% |
| Return on Assets (ROA) | -15.7% | -13.6% | -12.6% | -70.8% | -69.0% | -71.7% | -72.7% | -9.8% |
| Current Ratio | 1.76x | 1.87x | 1.99x | 2.20x | 0.81x | 0.81x | 0.81x | 0.82x |
| Quick Ratio | 0.86x | 0.98x | 1.06x | 1.25x | 0.41x | 0.41x | 0.40x | 0.40x |
| Debt to Equity | 8.68x | 5.96x | 4.39x | 3.22x | 3.04x | 2.78x | 3.04x | 0.70x |
| **Revenue Growth (YoY)** | +7.8% | +11.1% | -4.7% | -3.3% | -6.3% | -11.5% | -11.2% | -12.8% |
| Gross Profit Growth (YoY) | +2.4% | +9.5% | +0.5% | +1.1% | -5.8% | -12.7% | -17.5% | -14.2% |
| Operating Income Growth (YoY) | -683.8% | -- | -- | +15445.5% | -- | -- | -- | -96.1% |
| **Net Income Growth (YoY)** | -- | -- | -- | -15916.7% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -122.9% | -88.2% | -122.2% | -105.6% | -- | -- | +112.8% | -59.9% |
| Free Cash Flow Growth (YoY) | -234.0% | -113.6% | -144.0% | -138.3% | -- | -- | +226.3% | -59.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
